Clorox (NYSE:CLX) Stock Rating Upgraded by Wall Street Zen

Clorox (NYSE:CLX) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports.

Other equities analysts have also recently issued research reports about the stock. UBS Group reissued a “neutral” rating on shares of Clorox in a research report on Friday, September 11th. Deutsche Bank Aktiengesellschaft set a $98.00 target price on Clorox in a report on Tuesday, August 4th. Wells Fargo & Company dropped their price target on Clorox from $102.00 to $90.00 and set an “equal weight” rating on the stock in a report on Friday, September 11th. Zacks Research raised Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 14th. Finally, Jefferies Financial Group downgraded Clorox from a “buy” rating to a “hold” rating and reduced their price objective for the company from $125.00 to $98.00 in a research note on Tuesday, July 28th. Thirteen analysts have rated the stock with a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Reduce” and an average price target of $101.40.

Clorox Trading Up 0.1%

CLX opened at $83.17 on Friday. Clorox has a fifty-two week low of $83.09 and a fifty-two week high of $128.90. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The firm has a market capitalization of $10.06 billion, a price-to-earnings ratio of 17.26, a PEG ratio of 2.60 and a beta of 0.56. The company’s 50 day moving average price is $98.27 and its two-hundred day moving average price is $98.93.

Clorox (NYSE:CLX) last released its quarterly earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. The firm had revenue of $1.95 billion for the quarter, compared to analyst estimates of $1.91 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The business’s revenue was down 2.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.87 EPS. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, research analysts predict that Clorox will post 5.8 earnings per share for the current year.

Institutional Trading of Clorox

A number of institutional investors have recently bought and sold shares of CLX. BlackRock Inc. acquired a new position in shares of Clorox in the second quarter valued at about $958,640,000. Geode Capital Management LLC boosted its holdings in Clorox by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock valued at $318,613,000 after purchasing an additional 10,060 shares during the period. Van ECK Associates Corp increased its holdings in shares of Clorox by 15.7% during the fourth quarter. Van ECK Associates Corp now owns 3,136,405 shares of the company’s stock worth $316,244,000 after purchasing an additional 426,433 shares during the period. Bank of America Corp DE bought a new position in shares of Clorox during the second quarter worth approximately $179,780,000. Finally, Arrowstreet Capital Limited Partnership raised its position in shares of Clorox by 9.6% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 1,619,396 shares of the company’s stock valued at $163,284,000 after buying an additional 142,463 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company (NYSE: CLX) is a consumer products company that develops, manufactures and markets household, health and wellness, and lifestyle products. Its portfolio includes cleaning and disinfecting products, laundry and home-care items, food products, personal-care products, water-filtration systems, charcoal, and cat litter.

Clorox’s brands include Clorox bleach and disinfecting products, Pine-Sol, Fresh Step and Scoop Away, Kingsford, Brita, Burt’s Bees, Hidden Valley, and products marketed under the Glad name.